Most read articles by the same author(s)
- Eugenio Di Brino, Matteo Ruggeri, Stefania Boccia, Nicoletta Cerana, Domenica Lorusso, Dario Sacchini, Antonella Savarese, Liliana Varesco, Americo Cicchetti, A cost-minimization analysis of a preventive testing strategy for relatives of patients with BRCA mutated ovarian cancer , Global and Regional Health Technology Assessment: Vol. 7 No. 1 (2020): January-December 2020
- Stefano Fagiuoli, Matteo Ruggeri, Filipa Aragao, Rob Blissett, The Clinical and Economic Benefits of a New Paradigm of HCV Diagnosis and Treatment , Global and Regional Health Technology Assessment: Vol. 8 No. 1 (2021): January-December 2021
- Francesco S Mennini, Andrea Marcellusi, Chiara Bini, Maria Assunta Rotundo, Alessandro Giunta, Antonio Gasbarrini, Guido Valesini, Pier Luigi Canonico, Ettore Novellino, Valentina Orlando, Alessandra Mecozzi, Teresa Gamucci, Livio Pagano, Eugenio Di Brino, Matteo Ruggeri, Americo Cicchetti, The economic impact of biosimilars in Italy: a scenario analysis , Global and Regional Health Technology Assessment: Vol. 6 No. 1 (2019): January-December 2019
- Matteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, Gabriele Righi, A cost-effectiveness analysis of Navina Smart on adult patients affected by neurogenic bowel dysfunction , Global and Regional Health Technology Assessment: Vol. 11 No. 1: January-December 2024
- Francesco S. Mennini, Lara Gitto, Roberto Scrivo, Filippo Drago, Marco Iezzi, Lorenzo Terranova, Matteo Ruggeri, Andrea Marcellusi, Simone Russo, Raffaella Viti, Americo Cicchetti, The Promotion of Drug Innovation in Italy: Critical Aspects and Unsolved Problems: La Valorizzazione Dell'Innovazione Farmaceutica in Italia: Aspetti Critici e Problemi Aperti , Global and Regional Health Technology Assessment: Vol. 3 No. 1 (2016): January-April 2016
- Matteo Ruggeri, Michele Basile, Alessandro Armuzzi, Americo Cicchetti, Activity-based costing and budget analysis of vedolizumab versus conventional treatments in ulcerative colitis and Crohn's disease: Analisi Organizzativa e di Budget Dell'introduzione di Vedolizumab Vs Terapie Tradizionali in Colite Ulcerosa e Morbo di Crohn , Global and Regional Health Technology Assessment: Vol. 4 No. 1 (2017): January-December 2017
- Marco Marchetti, Luz Irene Urbina, Marco Oradei, Matteo Ruggeri, Pierluigi Navarra, Intravitreal corticosteroids for the treatment of macular edema: review and assessment of quality of the evidence: Corticosteroidi per via Intravitreale per il Trattamento Dell'edema Maculare: Revisione e Valutazione Della Qualità Dell'evidenza , Global and Regional Health Technology Assessment: Vol. 4 No. 1 (2017): January-December 2017
- Matteo Ruggeri, Andrea Aiello, Anna D’Ausilio, Eugenio Di Brino, Salvatore Cottone, Angelo Ghezzi, Lorella Lombardozzi, Alessandra Mecozzi, Dario Sacchini, Alessandro Roccia, Monica Mangone, Mondher Toumi, Evolution of the Healthcare Expenditure in Italy and Effects of Fingolimod Increased Prescribing in Second Line Treatment of Relapsing-Remitting Multiple Sclerosis: Evoluzione della spesa sanitaria in Italia ed effetti della prescrizione di fingolimod in seconda linea nella sclerosi multipla recidivante-remittente , Global and Regional Health Technology Assessment: Vol. 3 No. 3 (2016): September-December 2016
- Paola Codella, Silvia Coretti, Alessandra Fiore, Giuliano Rizzardini, Matteo Ruggeri, Cost-Effectiveness Studies in HIV Treatment with Lopinavir/Ritonavir: A Review: Sostenibilità economica ed implicazioni di policy nell'implementazione di nuove strategie per la gestione dell'HIV. Una lettura critica basata sulle evidenze di costo-efficacia del regime terapeutico lopinavir/ritonavir , Global and Regional Health Technology Assessment: Vol. 1 No. 2 (2014): July-December 2014




